EP
GH icon

Essential Partners’s Guardant Health GH Stock Holding History

Essential Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15K Buy
41
+11
+37% +$1.2K ﹤0.01% 1445
2026
Q1 		$2.77K Hold
30
– – ﹤0.01% 1858
2025
Q4 		$3.06K Buy
30
+2
+7% +$179 ﹤0.01% 1632
2025
Q3 		$1.75K Buy
28
+17
+155% +$925 ﹤0.01% 1831
2025
Q2 		$572 Buy
+11
New +$491 ﹤0.01% 1664

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Essential Partners's GH Position: Q2 2026 in Review

Essential Partners increased its Guardant Health (GH) stake by 37% in Q2 2026, buying an estimated $1.2K and bringing the position to 41 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

Essential Partners first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Essential Partners held 41 shares of Guardant Health worth $6.15K as of Q2 2026.
  • Essential Partners bought 11 Guardant Health shares in Q2 2026, an estimated $1.2K.
  • Guardant Health made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1445 holding.
  • Essential Partners first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.